Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.
about
The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease.Paclitaxel-eluting stents versus sirolimus-eluting stents in patients with diabetes mellitus undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies.The need for sex-specific precision biomarkers for antiplatelet therapies.Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.Duration of dual antiplatelet therapy in acute coronary syndromeDual antiplatelet therapy after coronary stenting.Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.Duration of dual antiplatelet therapy (DAPT): a call for personalized medicine.Translation from the data of clinical trials to precision medicine: limitation of the current risk score for predicting coronary thrombosis and major bleedingMore, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions.Comparison of treatment outcomes of ticagrelor and clopidogrel among patients undergoing percutaneous coronary intervention: A meta-analysis.The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts.Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome.Higher Risk of Bleeding in Asians Presenting With ST-Segment Elevation Myocardial Infarction: Analysis of the National Inpatient Sample Database.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations.Improving Outcomes in High-Risk Percutaneous Coronary Interventions and Newer-Generation Drug-Eluting Stents: Good, But Not Good Enough.New scoring model (DARSYM score) to predict post-discharge bleeding after successful second-generation drug-eluting stent implantation.Antiplatelet therapy: New score for predicting bleeding risk after DAPT.Individualized Antiplatelet Therapy: A Long Way to Go.Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO-Kyoto Thrombotic and Bleeding Risk Scores.Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.Evaluation of the Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Bleeding Score for Predicting the Long-term Out-of-hospital Bleeding Risk in Chinese Patients after Percutaneous Coronary Intervention.Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trialPractical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSIncidence and prognostic implications of late bleeding events after percutaneous mitral valve repairEffects of tirofiban on stent thrombosis, Hs-CRP, IL-6 and sICAM-1 after PCI of acute myocardial infarction
P2860
Q30234909-2E936213-4F8F-4E95-A5E9-070900C68209Q36134009-A082F0A2-3B5F-46B4-876D-F92E91569BACQ38635747-E24B208C-B969-44AF-A4C9-5B411DB426FBQ38638383-44339EC7-4E63-4C53-9680-CEDCD848ADAAQ38704416-A0F09AC1-E8A7-4CB5-9D68-A700EA14AF4CQ38751834-AFD0965E-158C-4915-940E-95DA608C5313Q38866836-4151E052-22A7-4CFD-A0A0-F5BE21E6C811Q38894581-D130E9F5-9C87-45C0-858C-FB23A93C45B0Q38938316-BD1EEB07-373D-481B-A920-5E44CE13F4C1Q42369292-EC1C9268-C3D6-45C8-A34C-9DB00F7B4F5DQ42384622-C0650E3A-E1F6-4087-B57E-CDAB3E3C99F7Q47709533-251227F2-5B7B-4E47-97C5-2550694020C7Q47744395-CA2CCD89-7486-4018-AE67-582C39341889Q47865745-F44BFB44-B58C-4C3E-A652-E8AE2EC6FC02Q48165705-16CF1945-2379-4C33-82F9-2A4985C530EFQ48348319-A9AE44C3-7CD2-4007-B0C7-94C9A31E4264Q50089557-C166B31B-8EE4-492D-8B0B-FE4A14F4D71EQ50096699-CA31A993-F0C4-48D4-9D8A-9C3EB8202990Q53225036-F87D2690-86BA-47E5-9EDC-EC2169315C6DQ53256913-C2880102-2CF9-4419-B284-E838B09AA42CQ53293321-E545504F-1566-49BD-A88B-08FCD8AB65EFQ55384929-8AAB90F5-1658-41E3-8FFB-2B167DAFA4BDQ55416502-5C3D68F0-D2A4-4C2C-A442-73469638DE8BQ55425237-C8130D2B-E72A-463B-9430-8F07CA3AF97CQ55482186-973F24A7-C908-4481-8948-0D2941B6E74FQ57044145-106379D9-43AF-4B8D-837D-E09F75B2E03DQ57154436-ACF4EC73-775A-4295-A973-E28BCBE7A042Q57621041-05F1428C-1B28-4C2C-A585-D44E1B534D43Q58718637-4BAA4369-E012-4A07-8FC6-A472B33008E6Q58794887-D1FAEBC3-1D81-4EA8-8760-717A7B01E14C
P2860
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Coronary Thrombosis and Major ...... tents: Risk Scores From PARIS.
@en
type
label
Coronary Thrombosis and Major ...... tents: Risk Scores From PARIS.
@en
prefLabel
Coronary Thrombosis and Major ...... tents: Risk Scores From PARIS.
@en
P2093
P50
P1476
Coronary Thrombosis and Major ...... tents: Risk Scores From PARIS.
@en
P2093
Annapoorna S Kini
Antonio Colombo
C Michael Gibson
Claire Litherland
Cono Ariti
David J Cohen
Gennaro Giustino
Giora Weisz
Gregg W Stone
Mitchell W Krucoff
P304
P356
10.1016/J.JACC.2016.02.064
P407
P50
P577
2016-04-06T00:00:00Z